Top Markets
#1 Ontology Gas Ontology Gas +46.81%
#2 Verus Coin Verus Coin +22.52%
#3 EXOD EXOD +22.08%
#4 Fake World Assets Fake World Assets +22.08%
#5 ETHGas ETHGas +21.14%
#6 Status Status +17.96%
#7 Geodnet Geodnet +17.50%
#8 The Black Bull The Black Bull +16.80%
#9 Derive Derive +11.99%
#10 Ontology Ontology +11.87%
Coin of the day
Ontology Gas Ontology Gas
Settings
Language
ENGLISH
Currency
USD
Theme
PharmGen Science, Inc. PharmGen Science, Inc.

PharmGen Science, Inc.

004720
Rank in Stocks #25692
PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical... PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical Limited, is a South Korean company primarily involved in the research, development, manufacturing, and distribution of pharmaceutical products. Based in Hwaseong, South Korea, the firm offers a diverse portfolio encompassing prescription medications, over-the-counter drugs, nutritional supplements, and cosmetic items. These are available in various forms, including tablets, hard capsules, granules, ointments, syrups, and suspensions.
Share Price
$2.13
Market Cap
$46.67M
Change (1 day)
-3.75%
Change (1 year)
-33.04%
Country
KR
Trade PharmGen Science, Inc. (004720)

Category

Healthcare
Earnings for PharmGen Science, Inc. (004720)
Earnings in 2026 TTM: 0
According to PharmGen Science, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for PharmGen Science, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US